VALGANCICLOVIR hydrochloride, eq. 450mg base, tab.
STD
DORAVALG4T-
Valid Article
Account code:
60000
HS Code:
300490
Last Updated on:
07/11/2024, 18:08:37
Former
Code(s):
-X
6.4.3 - Other antivirals
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AB14
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
VALGANCICLOVIR
Therapeutic Action
Cytomegalovirus (CMV) nucleoside analogue, DNA polymerase inhibitor
Indications
Treatment of cytomegalovirus retinitis (CMVr)
Some restricted information has been hidden. Sign in
to see this information
Instructions for use
Tablets should not be broken or crushed.
Precautions for Use
Avoid direct contact of broken or crushed tablets with the skin or mucous membranes. In case of contact, wash thoroughly with water.
Valganciclovir is considered potentially teratogenic and carcinogenic. Barrier contraceptive precautions should be observed during and after treatment (refer to manufacturer's instructions).
Storage
Below 25ºC